DCF Advisers LLC raised its stake in shares of LENSAR, Inc. (NASDAQ:LNSR – Free Report) by 1.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 241,484 shares of the company’s stock after purchasing an additional 3,250 shares during the quarter. DCF Advisers LLC owned 2.12% of LENSAR worth $1,087,000 as of its most recent filing with the Securities and Exchange Commission.
LENSAR Price Performance
LENSAR stock opened at $4.31 on Friday. The business has a 50 day simple moving average of $4.68 and a 200 day simple moving average of $4.19. The company has a market capitalization of $49.12 million, a PE ratio of -2.73 and a beta of 0.64. LENSAR, Inc. has a one year low of $1.80 and a one year high of $5.60.
LENSAR (NASDAQ:LNSR – Get Free Report) last released its quarterly earnings data on Thursday, August 8th. The company reported ($0.53) earnings per share (EPS) for the quarter. LENSAR had a negative return on equity of 30.69% and a negative net margin of 27.83%. The company had revenue of $12.64 million for the quarter.
LENSAR Profile
LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.
Read More
- Five stocks we like better than LENSAR
- Stock Market Upgrades: What Are They?
- Autohome’s Dividend and Buyback Make It a Strong EV Play
- How to Evaluate a Stock Before Buying
- Cracker Barrel Is at the Bottom of the Barrel: Time to Buy?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Why Shopify Stock Has Analysts Buzzing About Big Gains
Receive News & Ratings for LENSAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LENSAR and related companies with MarketBeat.com's FREE daily email newsletter.